scanX
Home
Brooks Laboratories

Brooks Laboratories

150.85
+2.95
(1.99%)
Live Chart
comparison:

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
25
18
21
21
21
15
14
14
14
7
13
21
15
11
14
15
18
17
14
20
19
13
30
21
15
17
21
18
22
15
16
12
13
16
24
22
18
18
21
Expenses
22
16
18
18
17
13
12
13
15
11
16
22
16
14
16
16
18
17
16
21
20
13
24
22
18
15
20
20
21
19
16
14
13
16
23
21
17
18
19
EBITDA
3
2
3
4
4
3
2
1
-1
-3
-3
-1
-2
-3
-1
-1
0
-0
-2
-1
-1
-0
6
-1
-3
2
2
-1
1
-4
-0
-1
-0
0
2
1
1
0
2
Operating Profit %
9 %
9 %
13 %
15 %
18 %
19 %
12 %
9 %
-5 %
-48 %
-21 %
-5 %
-12 %
-33 %
-11 %
-6 %
-16 %
-1 %
-14 %
-5 %
-4 %
-2 %
18 %
-3 %
-25 %
9 %
6 %
-9 %
2 %
-27 %
-2 %
-12 %
-1 %
0 %
7 %
5 %
2 %
2 %
7 %
Depreciation
0
0
0
0
0
0
0
0
1
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
1
0
0
Interest
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
3
2
3
3
4
2
1
1
-2
-5
-5
-3
-4
-6
-4
-3
-2
-3
-4
-3
-3
-3
3
-3
-6
1
1
-2
0
-5
-1
-2
-1
-1
1
1
0
-0
1
Tax
0
0
1
0
-1
1
0
1
-1
0
0
0
0
0
0
0
0
0
0
0
9
0
0
0
7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Profit
2
2
2
3
5
2
1
1
-1
-6
-3
-3
-2
-4
-2
-2
-7
-4
-2
-3
-16
-3
3
-3
-13
1
1
-2
0
-5
-1
-2
-1
-1
1
1
0
-0
1
EPS in ₹
1.45
0.94
1.05
1.73
2.86
1.01
0.45
0.30
-0.73
-3.63
-1.87
-1.62
-1.40
-0.83
-1.24
-1.33
-4.18
-2.31
-1.12
-1.67
-9.07
-1.17
1.35
-1.27
-5.17
0.56
0.42
-0.77
0.02
-1.85
-0.33
-0.84
-0.29
-0.22
0.46
0.23
0.10
-0.08
0.36
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
136
153
164
173
168
158
93
104
92
94
Fixed Assets
16
16
126
125
118
113
15
15
15
14
Current Assets
55
30
22
31
32
38
25
37
28
31
Capital Work in Progress
53
87
0
1
0
0
0
1
0
0
Investments
0
0
0
0
0
0
47
47
47
47
Other Assets
67
49
38
48
50
45
31
40
31
34
Total Liabilities
136
153
164
173
168
158
93
104
92
94
Current Liabilities
22
28
24
41
47
46
26
36
33
23
Non Current Liabilities
2
3
12
18
15
14
3
3
3
2
Total Equity
111
122
128
115
105
98
64
65
57
70
Reserve & Surplus
95
106
112
98
89
74
40
40
32
43
Share Capital
16
16
16
16
16
25
25
25
25
26
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
1
-1
-0
1
2
-2
-0
0
-0
0
Investing Activities
-1
-14
-17
-5
1
-2
-1
1
-0
0
Operating Activities
2
8
10
-6
-5
-9
-1
3
1
-10
Financing Activities
-0
4
7
12
6
10
1
-4
-0
10
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Aug 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
66.41 %
66.41 %
66.41 %
66.41 %
66.41 %
66.41 %
66.41 %
66.41 %
66.41 %
66.41 %
63.59 %
63.59 %
63.59 %
63.59 %
63.59 %
63.59 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.02 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.06 %
0.06 %
0.00 %
1.25 %
2.46 %
3.86 %
3.86 %
3.86 %
3.86 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
28.74 %
28.92 %
28.73 %
28.84 %
28.79 %
28.75 %
28.20 %
27.80 %
27.72 %
27.84 %
27.80 %
26.89 %
25.21 %
25.55 %
25.57 %
28.55 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,813.45 4,33,187.90 38.62 49,887.20 12.06 9,648 27.34 52.25
Cipla
1,447.30 1,16,724.70 25.30 26,520.70 14.17 4,155 12.95 37.82
Mankind Pharma
2,641.85 1,06,188.70 50.21 10,615.60 19.57 1,942 28.89 53.71
Dr Reddys Laboratories
1,246.35 1,03,909.90 19.47 28,905.40 12.36 5,578 -9.47 50.88
Zydus Life Science
978.50 98,258.70 22.95 19,831.50 13.82 3,831 14.57 49.68
Lupin
2,076.75 96,694.30 36.77 20,141.50 19.94 1,936 73.53 46.28
Aurobindo Pharma
1,208.40 70,544.20 19.52 29,559.20 17.55 3,169 8.66 28.40
Alkem Laboratories
5,372.55 64,986.60 29.92 12,978.40 9.84 1,812 14.16 35.32
Glenmark Pharmaceuticals
1,518.15 43,317.30 - 12,653.10 6.58 -1,831 675.49 42.11
Biocon
352.80 42,825.40 30.69 15,621.20 35.25 1,298 -84.31 48.73

Corporate Action

Technical Indicators

RSI(14)
Neutral
65.72
ATR(14)
Less Volatile
3.13
STOCH(9,6)
Overbought
85.56
STOCH RSI(14)
Overbought
100.00
MACD(12,26)
Bullish
1.26
ADX(14)
Weak Trend
13.59
UO(9)
Bearish
84.87
ROC(12)
Uptrend And Accelerating
4.76
WillR(14)
Overbought
0.00
Bearish
4
Neutral
3
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Price & Volume Screeners
Candlestick Screeners
Fundamental Screeners
Intraday Screeners
Technical Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.